We built our evaluation around six criteria that genuinely matter for patients paying without insurance: Transparent pricing clear monthly cost, no hidden membership fees, no bait-and-switch tier escalations Medication options compounded semaglutide and tirzepatide availability, brand-name access where applicable, alternative formats (oral, sublingual) for needle-averse patients FDA compliance current marketing language reviewed against FDA enforcement standards, warning letter history checked against the FDA database, pharmacy partner transparency Clinical infrastructure licensed US-based clinicians, named medical advisory groups, LegitScript certification where applicable Patient support provider messaging access, dose adjustment policies, included coaching or nutrition guidance Trust signals third-party reviews (Trustpilot, BBB), refund or guarantee policies, cancellation transparency We cross-referenced every program in this roundup against the FDA warning letter database (covering both the September 2025 and February 2026 enforcement waves) and verified current website language for compliance
One of the newest names generating interest is retatrutide, a medication currently being studied for its potential to support significant weight loss and metabolic improvements
Effects of the insulin sensitizer metformin in Alzheimer disease: pilot data from a randomized placebo-controlled crossover study
But as with any new medication or weight management method, this class of drugs brings with it many questions
C., & Simon, J
Our team is dedicated to helping you achieve sustainable results through personalized weight loss plans, advanced medical care, and continuous support
